Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Shares Outstanding (2020 - 2025)

Bio Essence (BIOE) has 6 years of Shares Outstanding data on record, last reported at $38.0 million in Q3 2025.

  • For Q3 2025, Shares Outstanding changed 0.0% year-over-year to $38.0 million; the TTM value through Sep 2025 reached $38.0 million, changed 0.0%, while the annual FY2024 figure was $38.0 million, 0.0% changed from the prior year.
  • Shares Outstanding reached $38.0 million in Q3 2025 per BIOE's latest filing, roughly flat from $38.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $38.0 million in Q2 2023 and bottomed at $33.0 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $35.6 million, with a median of $38.0 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: changed 0.0% in 2021, then rose 15.15% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022, then grew by 15.15% to $38.0 million in 2023, then changed by 0.0% to $38.0 million in 2024, then changed by 0.0% to $38.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $38.0 million in Q3 2025, $38.0 million in Q2 2025, and $38.0 million in Q1 2025.